CAMBfix is a Cambridge University spin-off which was founded in 2004 and incorporated in 2006. It has successfully incubated new technologies and brought them from the bench-to-bedside by carrying out cutting edge in-house research and extensive multinational research collaborations.
The goal of Cambfix is to provide innovative, high quality medical devices for use in orthopaedic and trauma surgery. Our first generation products utilise Cambfix’s patented platform technology to develop devices focusing on fracture treatment. We will work in collaboration with world-class surgeons in order to continue to develop novel concepts which have real, tangible use in surgery and post-operative recovery.
Why Cambfix for Orthopaedic and trauma devices?
The company draws together
Cambfix has developed a platform technology to provide a comprehensive trauma fixation system. This can be used for initial stabilisation and definitive management of fractures. There is a substantial unmet need in the trauma field, for example, every year there are 1.5 million ankle and wrist fractures in the US and Europe. This costs the combined healthcare industry over $3 billion.
Over a third of these cases develop a complication during treatment such as infection, stiffness, loss of fracture position and loss of productivity. Cambfix’s first generation products have a patented technology (fully owned by Cambfix limited) that addresses these concerns in their entirety and can thereby save the healthcare industry $8 million in ankle and wrist fractures alone.
Technology advantages include